bluebird bio (BLUE)
(Real Time Quote from BATS)
$0.50 USD
+0.01 (1.07%)
Updated Oct 11, 2024 12:32 PM ET
2-Buy of 5 2
D Value B Growth A Momentum C VGM
Income Statements
Fiscal Year end for bluebird bio, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 30 | 4 | 4 | 251 | 45 |
Cost Of Goods | 34 | 10 | 39 | 5 | 3 |
Gross Profit | -4 | -6 | -35 | 245 | 42 |
Selling & Adminstrative & Depr. & Amort Expenses | 240 | 281 | 556 | 868 | 857 |
Income After Depreciation & Amortization | -244 | -287 | -591 | -623 | -815 |
Non-Operating Income | 49 | 21 | 29 | 5 | 25 |
Interest Expense | 16 | 0 | 0 | 0 | 0 |
Pretax Income | -212 | -266 | -562 | -618 | -790 |
Income Taxes | 0 | 0 | 0 | 1 | -1 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -212 | -267 | -563 | -619 | -790 |
Extras & Discontinued Operations | 0 | 0 | -257 | 0 | 0 |
Net Income (GAAP) | -212 | -267 | -819 | -619 | -790 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -216 | -282 | -571 | -604 | -797 |
Depreciation & Amortization (Cash Flow) | 29 | 5 | 20 | 19 | 17 |
Income After Depreciation & Amortization | -244 | -287 | -591 | -623 | -815 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 109.83 | 78.59 | 68.19 | 62.18 | 55.19 |
Diluted EPS Before Non-Recurring Items | -1.93 | -3.30 | -7.86 | -9.95 | -14.31 |
Diluted Net EPS (GAAP) | -1.93 | -3.39 | -11.89 | -9.95 | -14.31 |
Fiscal Year end for bluebird bio, Inc falls in the month of December .
All items in Millions except EPS data.
9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | |
---|---|---|---|---|---|
Sales | NA | 16.10 | 18.57 | 7.83 | 12.39 |
Cost Of Goods | NA | 28.95 | 25.86 | 9.63 | 10.96 |
Gross Profit | NA | -12.85 | -7.29 | -1.80 | 1.44 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 75.55 | 71.40 | 80.87 | 86.16 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -88.40 | -78.69 | -82.67 | -84.72 |
Non-Operating Income | NA | 12.47 | 13.74 | 10.47 | 13.00 |
Interest Expense | NA | 5.45 | 4.86 | 16.35 | 0.00 |
Pretax Income | NA | -81.37 | -69.80 | -88.56 | -71.73 |
Income Taxes | NA | 0.02 | 0.00 | -0.05 | 0.00 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -81.39 | -69.80 | -88.51 | -71.73 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -81.39 | -69.80 | -88.51 | -71.73 |
Earnings Per Share Data | 9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 |
---|---|---|---|---|---|
Average Shares | NA | 193.72 | 193.15 | 114.14 | 109.10 |
Diluted EPS Before Non-Recurring Items | NA | -0.42 | -0.36 | -0.78 | -0.66 |
Diluted Net EPS (GAAP) | NA | -0.42 | -0.36 | -0.81 | -0.66 |